A Study to measure effectiveness of individualized homoeopathicmanagement in cases of type-2 diabetes mellitus by observing changes in HbA1c lab reports.
- Conditions
- Health Condition 1: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2024/07/070649
- Lead Sponsor
- Mayank Kanubhai Roy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Cases pre-diagnosed or having clinical features of type 2 diabetes
mellitus.
2. The patients giving their consent to participate in study with minimum
six follow ups.
3. HbA1c level is 6.5% or Above
4. Age- 18 to 58 years and of both sexes.
5. Patients who are not taking any medication.
6. Patients who have stopped medication 3 moths before induction.
1. Age below 18 years and above 58 years.
2. Pregnant and lactating patients.
3. Patient with Serious complication with inflammatory changes.
4. Cases with less than 6 follow up.
5. Patient Diagnosed with G6PD deficiency (glucose-6-phosphatedehydrogenase
deficiency).
6. Any patient found to be uncooperative during the study.
7. Unable to Speak Gujarati, Hindi or English.
8. Patients on any other medication.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HbA1c change reduced to less than 6.5%.Timepoint: HbA1c at every 3 months in treatment duration.
- Secondary Outcome Measures
Name Time Method Overall Lifestyle changesTimepoint: relief in symptoms at every 4 weeks. with changes in FBS & PP2BS at gradual pace.